Global and Regional Protein Engineering

Protein Engineering Comprehensive Study by Type (Modified Enzymes, Insulin, Monoclonal Antibodies, Coagulation Factors (Blood factors + Tissue plasminogen), Vaccines, Growth Factors (Hormones + Cytokine), Others), Technology (Irrational Protein Design, Rational Protein Design), End User (Academic Research Institutes, Pharmaceutical & Biotechnology Companies, Contract Research Organizations) Players and Region - Global Market Outlook to 2026

Protein Engineering Market by XX Submarkets | Forecast Years 2022-2027 | CAGR: 14.29%  

Access Sample Report Make An Enquiry Before Purchase
  • Summary
  • Market Segments
  • Table of Content
  • List of Table & Figures
  • Players Profiled
Industry Background:
The factors driving the business growth of protein engineering market include growing consumption of protein-based drugs owing to protein deficiency as well as increasing government initiatives and funding for protein engineering will propel the business growth over the forecasted period. Protein engineering is a process of stabilizing and developing protein intake or any enzyme with particular applications. This process relates to the adoption of protein producing enzymes for the production of high value and required proteins. Variety of protein engineering methods are available in the market including directed and random mutagenesis, homology modelling. Molecular dynamics and many others.According to AMA, the market for Protein Engineering is expected to register a CAGR of 14.29% during the forecast period to 2026. This growth is primarily driven by Increasing Government Initiatives in Minimizing Protein Deficiency and Growing Prevalence of Protein Deficiency Diseases.

Globally, a noticeable market trend is evident Rising Adoption of Monoclonal Antibodies across the Globe . The Biotechnology sector in the North America region has been increasing at a sustainable rate and further growth is expected to be witnessed over the forecast period, owing to the robust investments and expansion in production facilities in the region. Major Players, such as Agilent Technologies Inc. (United States), Bio-Rad Laboratories, Inc. (United States), Lonza Group AG (Switzerland), Bruker Corporation (United States), Danaher Corporation (United States), General Electric Company (United States), PerkinElmer, Inc. (United States), GenScript Biotech Corporation (United States), Sigma-Aldrich Corporation (United States) and Thermo Fisher Scientific (United States) etc have either set up their manufacturing facilities or are planning to start new provision in the dominated region in the upcoming years.

Key Developments in the Market:
On April 3rd, 2019, Bruker Corporation has acquired the semiconductor mask repair and cleaning business of a leading provider of nano-machining and laser photomask repair equipment, ‘RAVE LLC’. The acquired business, which will continue to be operated in Delray Beach, Florida, has built a strong reputation around its comprehensive portfolio of nanoprobe and laser-based photomask repair products, as well as CO2 cryo-cleaning technology for photomask and wafer applications.
On April 02nd, 2019, a leader in life sciences, diagnostics and applied chemical markets, ‘Agilent Technologies Inc.’ has shipped a new instrument that offers laboratories with more affordable, low-throughput options for analyzing the quality of RNA and DNA samples. This system makes quality control in next-generation sequencing easier, faster, and more economical. Moreover, on April 03rd, 2019, Lonza has launched its new SYNETH range of polyglycerol esters, extremely versatile non-ionic emulsifiers and surfactants which help formulators strike the perfect balance between functionality, aesthetics and mildness.

Market Drivers
  • Increasing Government Initiatives in Minimizing Protein Deficiency
  • Growing Prevalence of Protein Deficiency Diseases

Market Trend
  • Rising Adoption of Monoclonal Antibodies across the Globe
  • Increasing Applications of Protein Engineering in Numerous Therapies for Autoimmune Diseases and Cancer

Restraints
  • Comparatively Expensive Protein Engineering Treatments
  • Growing Adoption of Protein-Based Drugs Leading to Increased Prevalence of Number of Diseases


Challenges
Higher Maintenance as well as Operational Expenses with respect to Costly Instruments and Tools and Lack of Skilled Workforce Available for Protein Engineering

AMA Research follow a focused and realistic research framework that provides the ability to study the crucial market dynamics in several regions across the world. Moreover, an in-depth assessment is mostly conducted by our analysts on geographical regions to provide clients and businesses the opportunity to dominate in niche markets and expand in emerging markets across the globe. This market research study also showcase the spontaneously changing Players landscape impacting the growth of the market. Furthermore, our market researchers extensively analyse the products and services offered by multiple players competing to increase their market share and presence.

Customization in the Report
AMA Research features not only specific market forecasts, but also include significant value-added commentary on:
- Market Trends
- Technological Trends and Innovations
- Market Maturity Indicators
- Growth Drivers and Constraints
- New Entrants into the Market & Entry/Exit Barriers
- To Seize Powerful Market Opportunities
- Identify Key Business Segments, Market Proposition & Gap Analysis

Against this Challenging Backdrop, Protein Engineering Study Sheds Light on
— The Protein Engineering Market status quo and key characteristics. To end this, Analyst at AMA organize and took survey of the Protein Engineering industry Players. The resultant snapshot serves as a basis for understanding why and how the industry can be expected to change.
— Where Protein Engineering industry is heading and what are the top priorities. Insights are drawn from financial analysis, the survey and interviews with key executives and industry experts.
— How every company in this diverse set of Players can best navigate the emerging competition landscape and follow a strategy that helps them position to hold value they currently claim, or capture the new addressable opportunity.

Report Objectives / Segmentation Covered

By Type
  • Modified Enzymes
  • Insulin
  • Monoclonal Antibodies
  • Coagulation Factors (Blood factors + Tissue plasminogen)
  • Vaccines
  • Growth Factors (Hormones + Cytokine)
  • Others
By Technology
  • Irrational Protein Design
  • Rational Protein Design

By End User
  • Academic Research Institutes
  • Pharmaceutical & Biotechnology Companies
  • Contract Research Organizations

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Increasing Government Initiatives in Minimizing Protein Deficiency
      • 3.2.2. Growing Prevalence of Protein Deficiency Diseases
    • 3.3. Market Challenges
      • 3.3.1. Higher Maintenance as well as Operational Expenses with respect to Costly Instruments and Tools
      • 3.3.2. Lack of Skilled Workforce Available for Protein Engineering
    • 3.4. Market Trends
      • 3.4.1. Rising Adoption of Monoclonal Antibodies across the Globe
      • 3.4.2. Increasing Applications of Protein Engineering in Numerous Therapies for Autoimmune Diseases and Cancer
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Protein Engineering, by Type, Technology, End User and Region (value) (2015-2020)
    • 5.1. Introduction
    • 5.2. Global Protein Engineering (Value)
      • 5.2.1. Global Protein Engineering by: Type (Value)
        • 5.2.1.1. Modified Enzymes
        • 5.2.1.2. Insulin
        • 5.2.1.3. Monoclonal Antibodies
        • 5.2.1.4. Coagulation Factors (Blood factors + Tissue plasminogen)
        • 5.2.1.5. Vaccines
        • 5.2.1.6. Growth Factors (Hormones + Cytokine)
        • 5.2.1.7. Others
      • 5.2.2. Global Protein Engineering by: Technology (Value)
        • 5.2.2.1. Irrational Protein Design
        • 5.2.2.2. Rational Protein Design
      • 5.2.3. Global Protein Engineering by: End User (Value)
        • 5.2.3.1. Academic Research Institutes
        • 5.2.3.2. Pharmaceutical & Biotechnology Companies
        • 5.2.3.3. Contract Research Organizations
      • 5.2.4. Global Protein Engineering Region
        • 5.2.4.1. South America
          • 5.2.4.1.1. Brazil
          • 5.2.4.1.2. Argentina
          • 5.2.4.1.3. Rest of South America
        • 5.2.4.2. Asia Pacific
          • 5.2.4.2.1. China
          • 5.2.4.2.2. Japan
          • 5.2.4.2.3. India
          • 5.2.4.2.4. South Korea
          • 5.2.4.2.5. Taiwan
          • 5.2.4.2.6. Australia
          • 5.2.4.2.7. Rest of Asia-Pacific
        • 5.2.4.3. Europe
          • 5.2.4.3.1. Germany
          • 5.2.4.3.2. France
          • 5.2.4.3.3. Italy
          • 5.2.4.3.4. United Kingdom
          • 5.2.4.3.5. Netherlands
          • 5.2.4.3.6. Rest of Europe
        • 5.2.4.4. MEA
          • 5.2.4.4.1. Middle East
          • 5.2.4.4.2. Africa
        • 5.2.4.5. North America
          • 5.2.4.5.1. United States
          • 5.2.4.5.2. Canada
          • 5.2.4.5.3. Mexico
  • 6. Protein Engineering: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2020)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. Agilent Technologies Inc. (United States)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. Bio-Rad Laboratories, Inc. (United States)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. Lonza Group AG (Switzerland)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. Bruker Corporation (United States)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. Danaher Corporation (United States)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. General Electric Company (United States)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. PerkinElmer, Inc. (United States)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. GenScript Biotech Corporation (United States)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
      • 6.4.9. Sigma-Aldrich Corporation (United States)
        • 6.4.9.1. Business Overview
        • 6.4.9.2. Products/Services Offerings
        • 6.4.9.3. Financial Analysis
        • 6.4.9.4. SWOT Analysis
      • 6.4.10. Thermo Fisher Scientific (United States)
        • 6.4.10.1. Business Overview
        • 6.4.10.2. Products/Services Offerings
        • 6.4.10.3. Financial Analysis
        • 6.4.10.4. SWOT Analysis
  • 7. Global Protein Engineering Sale, by Type, Technology, End User and Region (value) (2021-2026)
    • 7.1. Introduction
    • 7.2. Global Protein Engineering (Value)
      • 7.2.1. Global Protein Engineering by: Type (Value)
        • 7.2.1.1. Modified Enzymes
        • 7.2.1.2. Insulin
        • 7.2.1.3. Monoclonal Antibodies
        • 7.2.1.4. Coagulation Factors (Blood factors + Tissue plasminogen)
        • 7.2.1.5. Vaccines
        • 7.2.1.6. Growth Factors (Hormones + Cytokine)
        • 7.2.1.7. Others
      • 7.2.2. Global Protein Engineering by: Technology (Value)
        • 7.2.2.1. Irrational Protein Design
        • 7.2.2.2. Rational Protein Design
      • 7.2.3. Global Protein Engineering by: End User (Value)
        • 7.2.3.1. Academic Research Institutes
        • 7.2.3.2. Pharmaceutical & Biotechnology Companies
        • 7.2.3.3. Contract Research Organizations
      • 7.2.4. Global Protein Engineering Region
        • 7.2.4.1. South America
          • 7.2.4.1.1. Brazil
          • 7.2.4.1.2. Argentina
          • 7.2.4.1.3. Rest of South America
        • 7.2.4.2. Asia Pacific
          • 7.2.4.2.1. China
          • 7.2.4.2.2. Japan
          • 7.2.4.2.3. India
          • 7.2.4.2.4. South Korea
          • 7.2.4.2.5. Taiwan
          • 7.2.4.2.6. Australia
          • 7.2.4.2.7. Rest of Asia-Pacific
        • 7.2.4.3. Europe
          • 7.2.4.3.1. Germany
          • 7.2.4.3.2. France
          • 7.2.4.3.3. Italy
          • 7.2.4.3.4. United Kingdom
          • 7.2.4.3.5. Netherlands
          • 7.2.4.3.6. Rest of Europe
        • 7.2.4.4. MEA
          • 7.2.4.4.1. Middle East
          • 7.2.4.4.2. Africa
        • 7.2.4.5. North America
          • 7.2.4.5.1. United States
          • 7.2.4.5.2. Canada
          • 7.2.4.5.3. Mexico
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Protein Engineering: by Type(USD Million)
  • Table 2. Protein Engineering Modified Enzymes , by Region USD Million (2015-2020)
  • Table 3. Protein Engineering Insulin , by Region USD Million (2015-2020)
  • Table 4. Protein Engineering Monoclonal Antibodies , by Region USD Million (2015-2020)
  • Table 5. Protein Engineering Coagulation Factors (Blood factors + Tissue plasminogen) , by Region USD Million (2015-2020)
  • Table 6. Protein Engineering Vaccines , by Region USD Million (2015-2020)
  • Table 7. Protein Engineering Growth Factors (Hormones + Cytokine) , by Region USD Million (2015-2020)
  • Table 8. Protein Engineering Others , by Region USD Million (2015-2020)
  • Table 9. Protein Engineering: by Technology(USD Million)
  • Table 10. Protein Engineering Irrational Protein Design , by Region USD Million (2015-2020)
  • Table 11. Protein Engineering Rational Protein Design , by Region USD Million (2015-2020)
  • Table 12. Protein Engineering: by End User(USD Million)
  • Table 13. Protein Engineering Academic Research Institutes , by Region USD Million (2015-2020)
  • Table 14. Protein Engineering Pharmaceutical & Biotechnology Companies , by Region USD Million (2015-2020)
  • Table 15. Protein Engineering Contract Research Organizations , by Region USD Million (2015-2020)
  • Table 16. South America Protein Engineering, by Country USD Million (2015-2020)
  • Table 17. South America Protein Engineering, by Type USD Million (2015-2020)
  • Table 18. South America Protein Engineering, by Technology USD Million (2015-2020)
  • Table 19. South America Protein Engineering, by End User USD Million (2015-2020)
  • Table 20. Brazil Protein Engineering, by Type USD Million (2015-2020)
  • Table 21. Brazil Protein Engineering, by Technology USD Million (2015-2020)
  • Table 22. Brazil Protein Engineering, by End User USD Million (2015-2020)
  • Table 23. Argentina Protein Engineering, by Type USD Million (2015-2020)
  • Table 24. Argentina Protein Engineering, by Technology USD Million (2015-2020)
  • Table 25. Argentina Protein Engineering, by End User USD Million (2015-2020)
  • Table 26. Rest of South America Protein Engineering, by Type USD Million (2015-2020)
  • Table 27. Rest of South America Protein Engineering, by Technology USD Million (2015-2020)
  • Table 28. Rest of South America Protein Engineering, by End User USD Million (2015-2020)
  • Table 29. Asia Pacific Protein Engineering, by Country USD Million (2015-2020)
  • Table 30. Asia Pacific Protein Engineering, by Type USD Million (2015-2020)
  • Table 31. Asia Pacific Protein Engineering, by Technology USD Million (2015-2020)
  • Table 32. Asia Pacific Protein Engineering, by End User USD Million (2015-2020)
  • Table 33. China Protein Engineering, by Type USD Million (2015-2020)
  • Table 34. China Protein Engineering, by Technology USD Million (2015-2020)
  • Table 35. China Protein Engineering, by End User USD Million (2015-2020)
  • Table 36. Japan Protein Engineering, by Type USD Million (2015-2020)
  • Table 37. Japan Protein Engineering, by Technology USD Million (2015-2020)
  • Table 38. Japan Protein Engineering, by End User USD Million (2015-2020)
  • Table 39. India Protein Engineering, by Type USD Million (2015-2020)
  • Table 40. India Protein Engineering, by Technology USD Million (2015-2020)
  • Table 41. India Protein Engineering, by End User USD Million (2015-2020)
  • Table 42. South Korea Protein Engineering, by Type USD Million (2015-2020)
  • Table 43. South Korea Protein Engineering, by Technology USD Million (2015-2020)
  • Table 44. South Korea Protein Engineering, by End User USD Million (2015-2020)
  • Table 45. Taiwan Protein Engineering, by Type USD Million (2015-2020)
  • Table 46. Taiwan Protein Engineering, by Technology USD Million (2015-2020)
  • Table 47. Taiwan Protein Engineering, by End User USD Million (2015-2020)
  • Table 48. Australia Protein Engineering, by Type USD Million (2015-2020)
  • Table 49. Australia Protein Engineering, by Technology USD Million (2015-2020)
  • Table 50. Australia Protein Engineering, by End User USD Million (2015-2020)
  • Table 51. Rest of Asia-Pacific Protein Engineering, by Type USD Million (2015-2020)
  • Table 52. Rest of Asia-Pacific Protein Engineering, by Technology USD Million (2015-2020)
  • Table 53. Rest of Asia-Pacific Protein Engineering, by End User USD Million (2015-2020)
  • Table 54. Europe Protein Engineering, by Country USD Million (2015-2020)
  • Table 55. Europe Protein Engineering, by Type USD Million (2015-2020)
  • Table 56. Europe Protein Engineering, by Technology USD Million (2015-2020)
  • Table 57. Europe Protein Engineering, by End User USD Million (2015-2020)
  • Table 58. Germany Protein Engineering, by Type USD Million (2015-2020)
  • Table 59. Germany Protein Engineering, by Technology USD Million (2015-2020)
  • Table 60. Germany Protein Engineering, by End User USD Million (2015-2020)
  • Table 61. France Protein Engineering, by Type USD Million (2015-2020)
  • Table 62. France Protein Engineering, by Technology USD Million (2015-2020)
  • Table 63. France Protein Engineering, by End User USD Million (2015-2020)
  • Table 64. Italy Protein Engineering, by Type USD Million (2015-2020)
  • Table 65. Italy Protein Engineering, by Technology USD Million (2015-2020)
  • Table 66. Italy Protein Engineering, by End User USD Million (2015-2020)
  • Table 67. United Kingdom Protein Engineering, by Type USD Million (2015-2020)
  • Table 68. United Kingdom Protein Engineering, by Technology USD Million (2015-2020)
  • Table 69. United Kingdom Protein Engineering, by End User USD Million (2015-2020)
  • Table 70. Netherlands Protein Engineering, by Type USD Million (2015-2020)
  • Table 71. Netherlands Protein Engineering, by Technology USD Million (2015-2020)
  • Table 72. Netherlands Protein Engineering, by End User USD Million (2015-2020)
  • Table 73. Rest of Europe Protein Engineering, by Type USD Million (2015-2020)
  • Table 74. Rest of Europe Protein Engineering, by Technology USD Million (2015-2020)
  • Table 75. Rest of Europe Protein Engineering, by End User USD Million (2015-2020)
  • Table 76. MEA Protein Engineering, by Country USD Million (2015-2020)
  • Table 77. MEA Protein Engineering, by Type USD Million (2015-2020)
  • Table 78. MEA Protein Engineering, by Technology USD Million (2015-2020)
  • Table 79. MEA Protein Engineering, by End User USD Million (2015-2020)
  • Table 80. Middle East Protein Engineering, by Type USD Million (2015-2020)
  • Table 81. Middle East Protein Engineering, by Technology USD Million (2015-2020)
  • Table 82. Middle East Protein Engineering, by End User USD Million (2015-2020)
  • Table 83. Africa Protein Engineering, by Type USD Million (2015-2020)
  • Table 84. Africa Protein Engineering, by Technology USD Million (2015-2020)
  • Table 85. Africa Protein Engineering, by End User USD Million (2015-2020)
  • Table 86. North America Protein Engineering, by Country USD Million (2015-2020)
  • Table 87. North America Protein Engineering, by Type USD Million (2015-2020)
  • Table 88. North America Protein Engineering, by Technology USD Million (2015-2020)
  • Table 89. North America Protein Engineering, by End User USD Million (2015-2020)
  • Table 90. United States Protein Engineering, by Type USD Million (2015-2020)
  • Table 91. United States Protein Engineering, by Technology USD Million (2015-2020)
  • Table 92. United States Protein Engineering, by End User USD Million (2015-2020)
  • Table 93. Canada Protein Engineering, by Type USD Million (2015-2020)
  • Table 94. Canada Protein Engineering, by Technology USD Million (2015-2020)
  • Table 95. Canada Protein Engineering, by End User USD Million (2015-2020)
  • Table 96. Mexico Protein Engineering, by Type USD Million (2015-2020)
  • Table 97. Mexico Protein Engineering, by Technology USD Million (2015-2020)
  • Table 98. Mexico Protein Engineering, by End User USD Million (2015-2020)
  • Table 99. Company Basic Information, Sales Area and Its Competitors
  • Table 100. Company Basic Information, Sales Area and Its Competitors
  • Table 101. Company Basic Information, Sales Area and Its Competitors
  • Table 102. Company Basic Information, Sales Area and Its Competitors
  • Table 103. Company Basic Information, Sales Area and Its Competitors
  • Table 104. Company Basic Information, Sales Area and Its Competitors
  • Table 105. Company Basic Information, Sales Area and Its Competitors
  • Table 106. Company Basic Information, Sales Area and Its Competitors
  • Table 107. Company Basic Information, Sales Area and Its Competitors
  • Table 108. Company Basic Information, Sales Area and Its Competitors
  • Table 109. Protein Engineering: by Type(USD Million)
  • Table 110. Protein Engineering Modified Enzymes , by Region USD Million (2021-2026)
  • Table 111. Protein Engineering Insulin , by Region USD Million (2021-2026)
  • Table 112. Protein Engineering Monoclonal Antibodies , by Region USD Million (2021-2026)
  • Table 113. Protein Engineering Coagulation Factors (Blood factors + Tissue plasminogen) , by Region USD Million (2021-2026)
  • Table 114. Protein Engineering Vaccines , by Region USD Million (2021-2026)
  • Table 115. Protein Engineering Growth Factors (Hormones + Cytokine) , by Region USD Million (2021-2026)
  • Table 116. Protein Engineering Others , by Region USD Million (2021-2026)
  • Table 117. Protein Engineering: by Technology(USD Million)
  • Table 118. Protein Engineering Irrational Protein Design , by Region USD Million (2021-2026)
  • Table 119. Protein Engineering Rational Protein Design , by Region USD Million (2021-2026)
  • Table 120. Protein Engineering: by End User(USD Million)
  • Table 121. Protein Engineering Academic Research Institutes , by Region USD Million (2021-2026)
  • Table 122. Protein Engineering Pharmaceutical & Biotechnology Companies , by Region USD Million (2021-2026)
  • Table 123. Protein Engineering Contract Research Organizations , by Region USD Million (2021-2026)
  • Table 124. South America Protein Engineering, by Country USD Million (2021-2026)
  • Table 125. South America Protein Engineering, by Type USD Million (2021-2026)
  • Table 126. South America Protein Engineering, by Technology USD Million (2021-2026)
  • Table 127. South America Protein Engineering, by End User USD Million (2021-2026)
  • Table 128. Brazil Protein Engineering, by Type USD Million (2021-2026)
  • Table 129. Brazil Protein Engineering, by Technology USD Million (2021-2026)
  • Table 130. Brazil Protein Engineering, by End User USD Million (2021-2026)
  • Table 131. Argentina Protein Engineering, by Type USD Million (2021-2026)
  • Table 132. Argentina Protein Engineering, by Technology USD Million (2021-2026)
  • Table 133. Argentina Protein Engineering, by End User USD Million (2021-2026)
  • Table 134. Rest of South America Protein Engineering, by Type USD Million (2021-2026)
  • Table 135. Rest of South America Protein Engineering, by Technology USD Million (2021-2026)
  • Table 136. Rest of South America Protein Engineering, by End User USD Million (2021-2026)
  • Table 137. Asia Pacific Protein Engineering, by Country USD Million (2021-2026)
  • Table 138. Asia Pacific Protein Engineering, by Type USD Million (2021-2026)
  • Table 139. Asia Pacific Protein Engineering, by Technology USD Million (2021-2026)
  • Table 140. Asia Pacific Protein Engineering, by End User USD Million (2021-2026)
  • Table 141. China Protein Engineering, by Type USD Million (2021-2026)
  • Table 142. China Protein Engineering, by Technology USD Million (2021-2026)
  • Table 143. China Protein Engineering, by End User USD Million (2021-2026)
  • Table 144. Japan Protein Engineering, by Type USD Million (2021-2026)
  • Table 145. Japan Protein Engineering, by Technology USD Million (2021-2026)
  • Table 146. Japan Protein Engineering, by End User USD Million (2021-2026)
  • Table 147. India Protein Engineering, by Type USD Million (2021-2026)
  • Table 148. India Protein Engineering, by Technology USD Million (2021-2026)
  • Table 149. India Protein Engineering, by End User USD Million (2021-2026)
  • Table 150. South Korea Protein Engineering, by Type USD Million (2021-2026)
  • Table 151. South Korea Protein Engineering, by Technology USD Million (2021-2026)
  • Table 152. South Korea Protein Engineering, by End User USD Million (2021-2026)
  • Table 153. Taiwan Protein Engineering, by Type USD Million (2021-2026)
  • Table 154. Taiwan Protein Engineering, by Technology USD Million (2021-2026)
  • Table 155. Taiwan Protein Engineering, by End User USD Million (2021-2026)
  • Table 156. Australia Protein Engineering, by Type USD Million (2021-2026)
  • Table 157. Australia Protein Engineering, by Technology USD Million (2021-2026)
  • Table 158. Australia Protein Engineering, by End User USD Million (2021-2026)
  • Table 159. Rest of Asia-Pacific Protein Engineering, by Type USD Million (2021-2026)
  • Table 160. Rest of Asia-Pacific Protein Engineering, by Technology USD Million (2021-2026)
  • Table 161. Rest of Asia-Pacific Protein Engineering, by End User USD Million (2021-2026)
  • Table 162. Europe Protein Engineering, by Country USD Million (2021-2026)
  • Table 163. Europe Protein Engineering, by Type USD Million (2021-2026)
  • Table 164. Europe Protein Engineering, by Technology USD Million (2021-2026)
  • Table 165. Europe Protein Engineering, by End User USD Million (2021-2026)
  • Table 166. Germany Protein Engineering, by Type USD Million (2021-2026)
  • Table 167. Germany Protein Engineering, by Technology USD Million (2021-2026)
  • Table 168. Germany Protein Engineering, by End User USD Million (2021-2026)
  • Table 169. France Protein Engineering, by Type USD Million (2021-2026)
  • Table 170. France Protein Engineering, by Technology USD Million (2021-2026)
  • Table 171. France Protein Engineering, by End User USD Million (2021-2026)
  • Table 172. Italy Protein Engineering, by Type USD Million (2021-2026)
  • Table 173. Italy Protein Engineering, by Technology USD Million (2021-2026)
  • Table 174. Italy Protein Engineering, by End User USD Million (2021-2026)
  • Table 175. United Kingdom Protein Engineering, by Type USD Million (2021-2026)
  • Table 176. United Kingdom Protein Engineering, by Technology USD Million (2021-2026)
  • Table 177. United Kingdom Protein Engineering, by End User USD Million (2021-2026)
  • Table 178. Netherlands Protein Engineering, by Type USD Million (2021-2026)
  • Table 179. Netherlands Protein Engineering, by Technology USD Million (2021-2026)
  • Table 180. Netherlands Protein Engineering, by End User USD Million (2021-2026)
  • Table 181. Rest of Europe Protein Engineering, by Type USD Million (2021-2026)
  • Table 182. Rest of Europe Protein Engineering, by Technology USD Million (2021-2026)
  • Table 183. Rest of Europe Protein Engineering, by End User USD Million (2021-2026)
  • Table 184. MEA Protein Engineering, by Country USD Million (2021-2026)
  • Table 185. MEA Protein Engineering, by Type USD Million (2021-2026)
  • Table 186. MEA Protein Engineering, by Technology USD Million (2021-2026)
  • Table 187. MEA Protein Engineering, by End User USD Million (2021-2026)
  • Table 188. Middle East Protein Engineering, by Type USD Million (2021-2026)
  • Table 189. Middle East Protein Engineering, by Technology USD Million (2021-2026)
  • Table 190. Middle East Protein Engineering, by End User USD Million (2021-2026)
  • Table 191. Africa Protein Engineering, by Type USD Million (2021-2026)
  • Table 192. Africa Protein Engineering, by Technology USD Million (2021-2026)
  • Table 193. Africa Protein Engineering, by End User USD Million (2021-2026)
  • Table 194. North America Protein Engineering, by Country USD Million (2021-2026)
  • Table 195. North America Protein Engineering, by Type USD Million (2021-2026)
  • Table 196. North America Protein Engineering, by Technology USD Million (2021-2026)
  • Table 197. North America Protein Engineering, by End User USD Million (2021-2026)
  • Table 198. United States Protein Engineering, by Type USD Million (2021-2026)
  • Table 199. United States Protein Engineering, by Technology USD Million (2021-2026)
  • Table 200. United States Protein Engineering, by End User USD Million (2021-2026)
  • Table 201. Canada Protein Engineering, by Type USD Million (2021-2026)
  • Table 202. Canada Protein Engineering, by Technology USD Million (2021-2026)
  • Table 203. Canada Protein Engineering, by End User USD Million (2021-2026)
  • Table 204. Mexico Protein Engineering, by Type USD Million (2021-2026)
  • Table 205. Mexico Protein Engineering, by Technology USD Million (2021-2026)
  • Table 206. Mexico Protein Engineering, by End User USD Million (2021-2026)
  • Table 207. Research Programs/Design for This Report
  • Table 208. Key Data Information from Secondary Sources
  • Table 209. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Protein Engineering: by Type USD Million (2015-2020)
  • Figure 5. Global Protein Engineering: by Technology USD Million (2015-2020)
  • Figure 6. Global Protein Engineering: by End User USD Million (2015-2020)
  • Figure 7. South America Protein Engineering Share (%), by Country
  • Figure 8. Asia Pacific Protein Engineering Share (%), by Country
  • Figure 9. Europe Protein Engineering Share (%), by Country
  • Figure 10. MEA Protein Engineering Share (%), by Country
  • Figure 11. North America Protein Engineering Share (%), by Country
  • Figure 12. Global Protein Engineering share by Players 2020 (%)
  • Figure 13. Global Protein Engineering share by Players (Top 3) 2020(%)
  • Figure 14. Global Protein Engineering share by Players (Top 5) 2020(%)
  • Figure 15. BCG Matrix for key Companies
  • Figure 16. Agilent Technologies Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 17. Agilent Technologies Inc. (United States) Revenue: by Geography 2020
  • Figure 18. Bio-Rad Laboratories, Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 19. Bio-Rad Laboratories, Inc. (United States) Revenue: by Geography 2020
  • Figure 20. Lonza Group AG (Switzerland) Revenue, Net Income and Gross profit
  • Figure 21. Lonza Group AG (Switzerland) Revenue: by Geography 2020
  • Figure 22. Bruker Corporation (United States) Revenue, Net Income and Gross profit
  • Figure 23. Bruker Corporation (United States) Revenue: by Geography 2020
  • Figure 24. Danaher Corporation (United States) Revenue, Net Income and Gross profit
  • Figure 25. Danaher Corporation (United States) Revenue: by Geography 2020
  • Figure 26. General Electric Company (United States) Revenue, Net Income and Gross profit
  • Figure 27. General Electric Company (United States) Revenue: by Geography 2020
  • Figure 28. PerkinElmer, Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 29. PerkinElmer, Inc. (United States) Revenue: by Geography 2020
  • Figure 30. GenScript Biotech Corporation (United States) Revenue, Net Income and Gross profit
  • Figure 31. GenScript Biotech Corporation (United States) Revenue: by Geography 2020
  • Figure 32. Sigma-Aldrich Corporation (United States) Revenue, Net Income and Gross profit
  • Figure 33. Sigma-Aldrich Corporation (United States) Revenue: by Geography 2020
  • Figure 34. Thermo Fisher Scientific (United States) Revenue, Net Income and Gross profit
  • Figure 35. Thermo Fisher Scientific (United States) Revenue: by Geography 2020
  • Figure 36. Global Protein Engineering: by Type USD Million (2021-2026)
  • Figure 37. Global Protein Engineering: by Technology USD Million (2021-2026)
  • Figure 38. Global Protein Engineering: by End User USD Million (2021-2026)
  • Figure 39. South America Protein Engineering Share (%), by Country
  • Figure 40. Asia Pacific Protein Engineering Share (%), by Country
  • Figure 41. Europe Protein Engineering Share (%), by Country
  • Figure 42. MEA Protein Engineering Share (%), by Country
  • Figure 43. North America Protein Engineering Share (%), by Country
List of companies from research coverage that are profiled in the study
  • Agilent Technologies Inc. (United States)
  • Bio-Rad Laboratories, Inc. (United States)
  • Lonza Group AG (Switzerland)
  • Bruker Corporation (United States)
  • Danaher Corporation (United States)
  • General Electric Company (United States)
  • PerkinElmer, Inc. (United States)
  • GenScript Biotech Corporation (United States)
  • Sigma-Aldrich Corporation (United States)
  • Thermo Fisher Scientific (United States)
Additional players considered in the study are as follows:
Waters Corporation (United States) , Intrexon Corporation (United States)
Select User Access Type

Key Highlights of Report


Jul 2021 232 Pages 95 Tables Base Year: 2021 Coverage: 15+ Companies; 18 Countries

Request Sample Pages

Budget constraints? Get in touch with us for special pricing


Check Discount Now
Global and Regional Protein Engineering Quantitative research analysis
Global and Regional Protein Engineering Qualitative Industry Analysis
DOWNLOAD SAMPLE PDF

Talk to Our Experts

Want to Customize Study?


"We employ Market statistics, Industry benchmarking, Patent analysis, and Technological Insights to derive requirements and provide customize scope of work."

Make an Enquiry Now

Frequently Asked Questions (FAQ):

The Protein Engineering market is expected to see a CAGR of 14.29% during projected year 2020 to 2026.
Top performing companies in the Global Protein Engineering market are Agilent Technologies Inc. (United States), Bio-Rad Laboratories, Inc. (United States), Lonza Group AG (Switzerland), Bruker Corporation (United States), Danaher Corporation (United States), General Electric Company (United States), PerkinElmer, Inc. (United States), GenScript Biotech Corporation (United States), Sigma-Aldrich Corporation (United States) and Thermo Fisher Scientific (United States), to name a few.
North America is dominating the Protein Engineering Market.

Know More About Global and Regional Protein Engineering Report?

Have a Query? Click Here

Other Related Reports

Ginkgo Biloba Extract Comprehensive Study by Type (Tablets, Capsules, Liquid Extracts), Application (Food, Cosmetics, Pharmaceuticals), Distribution Channel (Offline, Online), End Use (Stroke and Oth...
$ 3650
Molecular Biology Enzymes Comprehensive Study by Type (Polymerases, Ligases, Restriction Endonucleases, Reverse Transcriptases, Phosphatases, Proteases and Proteinases, Other Enzymes), Application (P...
$ 3750
Chitin Comprehensive Study by Type (Beta Chitin, Alpha Chitin), Application (Agriculture, Industrial, Medicine, Others), Darivatives (Glucosamine, Chitosan) Players and Region - Global Market Outlook...
$ 3500
Cryopreservation Media Comprehensive Study by Type (Lysogenic broth, Protein-free media, Specialty media, Serum-free media, Chemically-defined media), Application (Biobanks, Gene Banks, Hospitals, Ti...
$ 3750
Bone Staples Comprehensive Study by Type (Knee, Hip, Wrist & Shoulder, Dental, Spine, Ankle, Others), Application (Knee Ligament Repair, Ankle Fracture, Triple Arthrodesis, Epiphysial Growth Arrest, ...
$ 3450
Human Immunoglobulin Comprehensive Study by Type (Intramuscular Injection, Intravenous Injection), Application (Disease Prevention, Treatment, Diagnosis, Other), End Users (Hospitals, Clinics, Home c...
$ 3750